Metraipolis › archive › dc_dc24bd888bb3

Retinal organoids: current status of development and new avenues for application in disease modeling, drug discovery and therapeutics — Europe PMC PMID:42070018

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42070018
DOI: 10.1186/s40942-[numero omesso]-x
License (as archived): solo-consultazione
Archived: 2026-11-02T21:13:39.749Z
SHA-256 of the archived text: 0ed3edce6e98bc4a6a17cc651cbf07b3acca7f4ca0373063dfe263c7e16d18ec
Stable URL of this page: https://metraipolis.com/documento/dc_dc24bd888bb3

How to cite

Retinal organoids: current status of development and new avenues for application in disease modeling, drug discovery and therapeutics — Europe PMC PMID:42070018 — Europe PMC (en), https://europepmc.org/article/MED/42070018 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc24bd888bb3 (Metraipolis archive dc_dc24bd888bb3, sha256 0ed3edce6e98bc4a6a17cc651cbf07b3acca7f4ca0373063dfe263c7e16d18ec)

BibTeX

@misc{dcdc24bd888bb3,
  title = {Retinal organoids: current status of development and new avenues for application in disease modeling, drug discovery and therapeutics — Europe PMC PMID:42070018},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42070018},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc24bd888bb3; sha256 0ed3edce6e98bc4a6a17cc651cbf07b3acca7f4ca0373063dfe263c7e16d18ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42070018. Agents can read the archived copy with the MCP tool read_document.